[Experimental study for active specific immunotherapy and immunochemotherapy using 3M KC1 solubilized tumor].
D000818:Animals; D000951:Antigens, Neoplasm / Q000627:therapeutic use*; D002478:Cells, Cultured; D004353:Drug Evaluation, Preclinical; D005354:Fibrosarcoma / Q000276:immunology / Q000628:therapy*; D006649:Histocompatibility Antigens / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D012513:Sarcoma, Experimental / Q000276:immunology / Q000628:therapy; D012995:Solubility
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; C029237:tumor-associated transplantation antigen